Pharma Industry Drives Innovation in Barrier/Isolation Design

Chiarello-Ebner,Kaylynn;

Pharma Industry Drives Innovation in Barrier/Isolation Design

March 2, 2004

By Kaylynn Chiarello-Ebner

Publication

Article

Pharmaceutical TechnologyPharmaceutical Technology-03-02-2004

Volume 28

Issue 3

The need to provide both operator and product protection while developing more efficient containment strategies has initiated a wave of innovative solutions in barrier/isolation equipment design and implementation.

External Link - article-87717.pdf

Articles in this issue

Pharmaceutical Pricing and Healthcare Access

The Effect of Buffers on Protein Conformational Stability

Packaging Helps Protect Temperature-Sensitive Products

Resealed Erythrocytes: A Review

Pharma Industry Drives Innovation in Barrier/Isolation Design

Connecting Clinical Trial Management to Pharmaceutical Manufacturing

March 2003

Stakes Getting Higher for Contractors

Related Content

The mRNA or messenger Ribonucleic Acid white text for medical or outbreak concept 3d rendering | Image Credit: ©niphon - adobe.stock.com

Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics

Cheryl Barton

June 24th 2025

Article

mRNA technologies offer great promise in immunotherapy and non-immunogenic applications.

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery

May 30th 2025

Podcast

In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.

Pharmacist weighing chemical | Image Credit: © Kzenon - stock.adobe.com

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

Paul L. Pluta;Nishant B. Thakar;Varanya Chaiyaperm

June 23rd 2025

Article

Bulk drug calculations for different types of active moieties and drugs require different calculations and labeling.

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific

March 28th 2025

Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.